Page 16 - AN-3-4
P. 16

Advanced Neurology                                                    LBD prevalence and incidence in India



            Appendix

            Appendix 1. Search strategy
            We primarily aimed to determine the most appropriate search terms that would help obtain pertinent and reliable information.
            Thus, HPK did extensive background reading and identified a set of search terms. These were then refined with the help of the
            medical research librarian and supervisor. The search was conducted on June 22, 2023, using the final search terms.
               1.  Incidence* OR Prevalence* OR Epidemiology* OR Diagnosis rate*
               2.  Lewy body Dementia or dementia with Lewy bodies or Parkinson’s disease dementia or Lewy body disease or dementia
                   subtypes or dementia* or Alzheimer disease or vascular dementia or frontotemporal dementia OR frontal lobe
                   dementia OR Korsakoff psychosis OR alcohol related Brain injury OR alcohol-related dementia OR Mixed dementia
               3.  India*
               4.  Andhra Pradesh OR Arunachal Pradesh OR Assam OR Bihar OR Chhattisgarh OR Goa OR Gujarat OR Haryana
                   OR Himachal Pradesh OR Jharkhand OR Karnataka OR Kerala OR Madhya Pradesh OR Maharashtra OR Manipur
                   OR Meghalaya OR Mizoram OR Nagaland OR Odisha OR Punjab OR Rajasthan OR Sikkim OR Tamil Nadu OR
                   Telangana OR Tripura OR Uttar Pradesh OR Uttarakhand OR West Bengal OR Ladakh OR Jammu & Kashmir
                   OR Puducherry OR Lakshadweep OR Delhi OR Chandigarh OR Dadra and Nagar Haveli and Daman & Diu OR
                   Andaman and Nicobar Islands
               5.  Amaravati OR Itanagar OR Patna OR Raipur OR Panaji OR Gandhinagar OR Chandigarh OR Shimla OR Ranchi
                   OR Bengaluru OR Thiruvananthapuram OR Bhopal OR Mumbai OR Imphal OR Shillong OR Aizawl OR Kohima OR
                   Bhubaneswar OR Chandigarh OR Jaipur OR Gangtok OR Chennai Hyderabad OR Agartala OR Dehradun OR Bhararisain
                   OR Kolkata OR Port Blair OR Daman OR New Delhi OR Srinagar OR Jammu OR Kavaratti OR Pondicherry OR Leh
               6.  3 OR 4 OR 5
               7.  1 AND 2 AND 6
               8.  Limit 7 to human
               9.  Limit 8 to English Language
               10.  Limit 9 to yr=”1996 -Current”
              We thoroughly researched all states, union territories, and corresponding capitals to ensure comprehensive and accurate
            data. The names of many states and cities were historically anglicized to reflect the UK’s colonial history in India (e.g., Madras,
            Bombay, Orissa, Pondicherry, and Bangalore). Since the turn of the millennium, the use of Indian names has become more
            common (e.g., Chennai, Mumbai, Odisha, Puducherry, and Bengaluru, respectively) when referring to these locations. To ensure
            that studies were not omitted based on naming conventions, both Indian and anglicized names were included in the search.
              The Lewy body dementia (LBD) data are provided in other dementia studies. LBD was also discussed in other dementia
            subtype studies. Therefore, several other dementia subtypes, such as Parkinson’s disease, Lewy body disease, dementia
            subtypes, Alzheimer’s disease, vascular dementia, frontotemporal dementia, frontal lobe dementia, Korsakoff psychosis,
            alcohol-related brain injury, alcohol-related dementia, and mixed dementia, were also incorporated into the search terms to
            ensure no missing data on DLB and PDD.
            Appendix 2. Quality assessment for the four studies included in the systematic reviews (primary aim)

            Table 1. Quality assessment of three cross‑sectional studies included in the review

            Cross‑sectional studies (Study name, year) ➤         Alladi et al., 2011  Banerjee et al., 2017  Patel et al., 2015
            Questions ▼
             1. Were the criteria for inclusion in the sample clearly defined?  Yes  Yes          Yes
             2. Were the study subjects and setting described in detail?  Yes    Yes              Yes
             3. Was the exposure measured in a valid and reliable manner?  Yes   Yes              Not applicable
             4. Were objective, standard criteria used for measurement of the condition?  Yes  No  Yes
             5. Were confounding factors identified?             Yes             No               Yes
             6. Were strategies to deal with confounding factors stated?  Not applicable  Not applicable  Not applicable
             7. Were the outcomes measured in a valid and reliable manner?  Yes  Yes              Yes
             8. Was appropriate statistical analysis used?       Yes             Not applicable   Not applicable
            Overall appraisal:                                   Include         Include          Include

            Volume 3 Issue 4 (2024)                         10                               doi: 10.36922/an.4098
   11   12   13   14   15   16   17   18   19   20   21